| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 710 | 2020 |
| B cell alterations during BAFF inhibition with belimumab in SLE D Ramsköld, I Parodis, T Lakshmikanth, N Sippl, M Khademi, Y Chen, ... EBioMedicine 40, 517-527, 2019 | 107 | 2019 |
| Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus I Parodis, C Sjöwall, A Jönsen, D Ramsköld, A Zickert, M Frodlund, ... Autoimmunity reviews 16 (4), 343-351, 2017 | 97 | 2017 |
| Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention M Kostopoulou, D Nikolopoulos, I Parodis, G Bertsias Current Vascular Pharmacology 18 (6), 549-565, 2020 | 96 | 2020 |
| Prediction of prognosis and renal outcome in lupus nephritis I Parodis, F Tamirou, FA Houssiau Lupus Science & Medicine 7 (1), e000389, 2020 | 87 | 2020 |
| B cell therapy in systemic lupus erythematosus: from rationale to clinical practice I Parodis, M Stockfelt, C Sjöwall Frontiers in Medicine 7, 316, 2020 | 62 | 2020 |
| Interferon (IFN)-λ is a potential mediator in lupus nephritis A Zickert, V Oke, I Parodis, E Svenungsson, Y Sundström, I Gunnarsson Lupus science & medicine 3 (1), e000170, 2016 | 57 | 2016 |
| Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis I Parodis, C Adamichou, S Aydin, A Gomez, N Demoulin, ... Rheumatology 59 (11), 3424-3434, 2020 | 54 | 2020 |
| ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus I Parodis, S Gokaraju, A Zickert, K Vanarsa, T Zhang, D Habazi, J Botto, ... Rheumatology 59 (9), 2237-2249, 2020 | 47 | 2020 |
| Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following … I Parodis, A Zickert, B Sundelin, M Axelsson, J Gerhardsson, ... Lupus science & medicine 2 (1), e000061, 2015 | 45 | 2015 |
| Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus I Parodis, P Johansson, A Gomez, S Soukka, S Emamikia, ... Rheumatology 58 (12), 2170-2176, 2019 | 43 | 2019 |
| Biologics in SLE: towards new approaches RF van Vollenhoven, I Parodis, A Levitsky Best Practice & Research Clinical Rheumatology 27 (3), 341-349, 2013 | 43 | 2013 |
| G-CSF-induced aortitis: two cases and review of the literature I Parodis, L Dani, A Notarnicola, G Martenhed, P Fernström, A Matikas, ... Autoimmunity Reviews 18 (6), 615-620, 2019 | 36 | 2019 |
| Antiphospholipid antibodies in lupus nephritis I Parodis, L Arnaud, J Gerhardsson, A Zickert, B Sundelin, V Malmström, ... PLoS One 11 (6), e0158076, 2016 | 35 | 2016 |
| The impact of belimumab and rituximab on health‐related quality of life in patients with systemic lupus erythematosus I Parodis, AH Lopez Benavides, A Zickert, S Pettersson, S Möller, ... Arthritis care & research 71 (6), 811-821, 2019 | 31 | 2019 |
| Autoantibody and cytokine profiles during treatment with belimumab in patients with systemic lupus erythematosus I Parodis, E Åkerström, C Sjöwall, A Sohrabian, A Jönsen, A Gomez, ... International Journal of Molecular Sciences 21 (10), 3463, 2020 | 29 | 2020 |
| Belimumab for systemic lupus erythematosus: a practice-based view I Parodis, M Axelsson, I Gunnarsson Lupus 22 (4), 372-380, 2013 | 29 | 2013 |
| Smoking reduces the efficacy of belimumab in mucocutaneous lupus I Parodis, A Gomez, M Frodlund, A Jönsen, A Zickert, C Sjöwall, ... Expert opinion on biological therapy 18 (8), 911-920, 2018 | 27 | 2018 |
| Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus–distinct roles of BAFF and APRIL I Parodis, F Söder, F Faustini, Z Kasza, I Samuelsson, A Zickert, ... Lupus 27 (9), 1470-1478, 2018 | 27 | 2018 |
| Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus A Gomez, F Hani Butrus, P Johansson, E Åkerström, S Soukka, ... Rheumatology 60 (3), 1260-1272, 2021 | 26 | 2021 |
